Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update
2024-07-26 19:00
Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Breakthroughs in Innovative Drug Project
2024-07-26 18:00
Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
2024-07-26 10:16
Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy
2024-07-25 20:00
IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication -- Systemic Lupus Erythematosus (SLE)
2024-07-25 17:46
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors
2024-07-22 08:00
Treatment of Type 2 diabetes with Chiglitazar combined with Metformin Approved for listing by the National Medical Products Administration
2024-07-19 22:01
Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results
2024-07-19 07:15
ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development
2024-07-19 00:00
Assessment of supply chain risk key to improving medicine access
2024-07-18 23:00
Duoning showcases its comprehensive bioprocess solutions at Interphex Korea 2024
2024-07-18 20:00
MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference
2024-07-18 13:19
Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse
2024-07-17 21:50
111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024
2024-07-17 13:31
GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities
2024-07-17 10:38
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks
2024-07-16 23:55
FDA Grants Orphan Drug Designation to 7MW3711
2024-07-16 22:00
Sanyou Bio Collaborates on ADC Drug Development Entering Phase I Clinical Trials
2024-07-16 20:00
Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC
2024-07-15 22:00
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
2024-07-15 19:00
1
4
5
6
7
8
159